Insider Transactions in Q4 2021 at Alx Oncology Holdings Inc (ALXO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,852
+6.14%
|
$23,852
$1.45 P/Share
|
|
Dec 13
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,390
-0.33%
|
$1,306,530
$27.91 P/Share
|
|
Dec 13
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
325,377
-1.3%
|
$8,785,179
$27.91 P/Share
|
|
Dec 10
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
26,274
-0.36%
|
$814,494
$31.49 P/Share
|
|
Dec 10
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
26,274
-0.36%
|
$814,494
$31.49 P/Share
|
|
Dec 09
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
76,905
-1.02%
|
$2,384,055
$31.96 P/Share
|
|
Dec 09
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
76,905
-1.02%
|
$2,384,055
$31.96 P/Share
|
|
Dec 08
2021
|
Lsv Associates, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,458
-0.82%
|
$1,401,114
$33.51 P/Share
|
|
Dec 08
2021
|
Jason Lettmann CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
42,458
-0.82%
|
$1,401,114
$33.51 P/Share
|
|
Nov 22
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,884
-8.3%
|
$535,824
$36.77 P/Share
|
|
Nov 22
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.32%
|
$120,000
$4.08 P/Share
|
|
Oct 19
2021
|
Jaume Pons PRESIDENT & CSO |
SELL
Open market or private sale
|
Direct |
33,400
-1.82%
|
$1,803,600
$54.64 P/Share
|
|
Oct 18
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,229
-8.94%
|
$404,824
$56.75 P/Share
|
|
Oct 18
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,229
+30.39%
|
$28,916
$4.08 P/Share
|
|
Oct 11
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-2.38%
|
$450,607
$61.08 P/Share
|